Kidney Cancer Statistics: Incidence, Deaths, Survival, and Risk
A data-focused overview of U.S. kidney cancer incidence, mortality, survival, lifetime risk, prevalence, and projected 2026 burden.
Statistics
Readable statistics and data-backed context for buyers who want more than feature lists and generic claims.
A data-focused overview of U.S. kidney cancer incidence, mortality, survival, lifetime risk, prevalence, and projected 2026 burden.
A source-labeled overview of kidney cancer surgery statistics, including nephrectomy trends, kidney function, complications, and survival findings.
See kidney cancer survival statistics by stage, age, sex, geography, and diagnosis period, with U.S. and UK comparisons from named cancer registries.
A statistics-focused guide to kidney cancer burden and targeted-therapy outcomes reported in major advanced renal cell carcinoma trials.
Review kidney cancer incidence, survival by stage, and measured outcomes from major treatment trials.
Explore U.S. kidney and renal pelvis cancer statistics, including distant-stage survival, stage distribution, rates, demographics, and trends.
Key papillary renal cell carcinoma statistics show differences in frequency, tumor features, stage, metastasis, and survival between type 1 and type 2 disease.
A detailed overview of renal cancer incidence, mortality, demographics, risk factors, cancer types, stage distribution, and survival statistics.
Explore current renal cell carcinoma statistics, including estimated U.S. cases and deaths, survival by stage, incidence patterns, age, sex, and major subtypes.
A source-labeled overview of chromophobe renal cell carcinoma frequency, outcomes, recurrence, pathology, and molecular features.
A data-focused overview of clear cell renal cell carcinoma frequency, molecular alterations, survival estimates, and treatment-study results.
Kidney cancer demographics vary by age, sex, race and ethnicity, with SEER and American Cancer Society statistics showing differences in incidence, mortality, stage, and survival.
Key U.S. statistics on kidney cancer diagnoses, including incidence, stage, age distribution, demographic differences, trends, and relative survival.
A source-labeled overview of kidney cancer immunotherapy statistics, including adjuvant pembrolizumab and advanced RCC treatment trials.
Kidney cancer incidence varies by age, sex, race and geography. These statistics summarize U.S. estimates, recent rates, trends and worldwide burden.
A source-labeled overview of kidney cancer mortality statistics worldwide and in the United States, including death counts, rates, trends, stage, and survival.
A fact-based review of kidney cancer recurrence statistics, including when relapse occurs, where it spreads, and how risk varies by tumor features.
Kidney cancer has no routine screening test for average-risk adults, but statistics clarify who is affected, hereditary risk, stage, and outcomes.